FindTrial
Sign In

The effect of naso-brain targeting of dexmedetomidine combined with auricular acupoint pressure therapy for sedation in children

The effect of naso-brain targeting of dexmedetomidine combined with auricular acupoint pressure therapy for sedation in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017920
Enrollment
Unknown
Registered
2018-08-22
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile congenital heart disease

Interventions

Experimental group:Auricular pressure therapy+ intranasal dexmedetomidine3mcg/kg
Control group:intranasal dexmedetomidine3mcg/kg

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.3 Years to 3 Years

Inclusion criteria

Inclusion criteria: Clinic heart colour to exceed examination for children with congenital heart disease in ASA II or III level, age 3 ~ 36 months, weight 5 ~ 20 kg, gender not limited

Exclusion criteria

Exclusion criteria: Patients with severe hepatic and renal insufficiency, arrhythmia, intelligent deficiency, and difficult airway were excluded

Design outcomes

Primary

MeasureTime frame
heart rate;blood pressure;oxyhemoglobin saturation;Consciousness index;—

Secondary

MeasureTime frame
UMMS score;Behavior score;—

Countries

China

Contacts

Public ContactYaying Huang

Guangzhou Women and Children's Medical Center

huangyaying1114@126.com+86 18198985617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026